We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Medtronic Acquires Medina Medical

By HospiMedica International staff writers
Posted on 14 Sep 2015
Print article
Image: The Medina Embolization Device (Photo courtesy of Medina Medical).
Image: The Medina Embolization Device (Photo courtesy of Medina Medical).
Medtronic (Dublin, Ireland) has acquired Medina Medical (Menlo Park, CA, USA), a privately-held company that has developed a novel embolization framing coil for treating brain aneurysms.

Medtronic had previously invested in Medina Medical and held an ownership stake in the company prior to completion of the all-cash acquisition, which includes an initial payment of USD 150 million, with additional payments conditional upon achievement of key milestones. Additional financial terms were not disclosed. The Medina Medical product line will join the company’s neurovascular division within the restorative therapies group.

“Medtronic is committed to fighting stroke through the innovative therapies we bring to clinicians and patients. Medina Medical's breakthrough technology makes it a natural fit with our Neurovascular portfolio, further strengthening our hemorrhagic stroke portfolio,” said Brett Wall, president of the neurovascular division at Medtronic. “The Medina embolization device features advanced technology to treat cerebral aneurysms that we think can one day disrupt the coil market.”

“This acquisition offers Medina Medical a unique opportunity to bring together our breakthrough technologies with Medtronic's leading clinical, regulatory, market development, and commercial expertise,” said Erik Engelson, CEO of Medina Medical. “We look forward to working closely with Medtronic to provide expanded access and economic efficiencies to our clinical partners in fighting stroke—particularly aneurysms and hemorrhagic stroke.”

The Medina Embolization Device is an intrasaccular 3-D mesh implant that is packed into a brain aneurysm. The technology addresses clinical needs by unfolding a 3-D self-expandable mesh to provide a scaffold across the aneurysm neck that conforms to the shape of the aneurysm and reduces blood flow. The embolization device has received the European Community CE marking, but has not yet been approved by the [US] Food and Drug Administration (FDA) for commercial distribution.

Related Links:

Medtronic
Medina Medical


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Glassware Washer
Tiva 10-1VL

Print article

Channels

Surgical Techniques

view channel
Image: Computational models can predict future structural integrity of a child’s heart valves (Photo courtesy of 123RF)

Computational Models Predict Heart Valve Leakage in Children

Hypoplastic left heart syndrome is a serious birth defect in which the left side of a baby’s heart is underdeveloped and ineffective at pumping blood, forcing the right side to handle the circulation to... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.